.png)
Mark J. Field PhD MSc FRSB
Neuroscientist
30 years pharma experience to Head of R&D
Creating Personalized Analgesics®
Founder of Eptiva Therapeutics & Analgesic Innovation
 |  |
|---|---|
 |
.jpeg)
.jpeg)
.jpeg)
Find out more about Analgesic Innovation (Ai)
Entrepreneur scientist with over 30 years’ experience developing new medicines in Neuroscience & Pain.
Unique expertise across both preclinical research & clinical development @ Pfizer, Parke-Davis, MSD & Grunenthal.
Currently CEO & Founder of Eptiva Therapeutics Ltd and Founder/Owner of Analgesic Innovation (Ai).
Find out more about Eptiva Therapeutics
PROJECTS
Back to Icons
Find out more about
Led the research that identified Gabapentin (Neurontin®) and Pregabalin (Lyrica®) as analgesics which generated peak annual revenues of over $5 Billion for Pfizer.
​
Associated with >30 compounds entering clinical trials.
​
Created a novel Personalized Analgesics® a bioinformatic network biology technology platform to link research targets to disease and de-risk pain R&D. This will help move much needed treatments closer to patients.
RESEARCH
Back to Icons
Explore MyBlog
for expert views on analgesic news
PhD and MSc degrees from Portsmouth University and Kings College London. My Research is documented in over 100 full-length Manuscripts, Abstracts and Patents with over 5000 citations and h-index of 34. Link to published research.
​
Independent R&D/analgesic expert - International speaker.
.jpeg)
CONTACT
Back to Icons
Contact me here
or on social media.
